ImmixBio Announces Helen C. Adams Joins Board of Directors
- Tuesday, July 13, 2021, 7:11
- Environment
- Add a comment
LOS ANGELES, July 13, 2021 /PRNewswire/ — Immix Biopharma, Inc. (“ImmixBio”), a biotechnology company pioneering Tissue-Specific Therapeutics (TSTx)™ for oncology and inflammation, today announced that accounting and financial expert Helen C. Adams, CFA has joined the Company’s Board of…
About the Author
adminasapcorp has written 41779 stories on this site.